Monopar Therapeutics MNPR Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Monopar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monopar Therapeutics's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monopar Therapeutics's operating lease right-of-use assets in other assets?
- Monopar Therapeutics (MNPR) reported operating lease right-of-use assets in other assets of $239.88K in Q1 2026.
- How has Monopar Therapeutics's operating lease right-of-use assets in other assets changed year-over-year?
- Monopar Therapeutics's operating lease right-of-use assets in other assets increased by 2535.5% year-over-year, from $9.1K to $239.88K.